Celldex Therapeutics Inc (CLDX)
Equity Ratio
91.34%
Quarterly · Period ending:

CLDX Equity Ratio
Latest reported91.34%period ending
Latest reported91.34%period ending
CLDX Quarterly Equity Ratio (-78.13% → 91.34%)
Latest values, visible window
High-resolution chart · PNG
CLDX equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 83.8061% | |
| 86.5076% | |
| 84.8481% | |
| 89.3174% | |
| 77.3808% | |
| 77.908% | |
| 87.5786% | |
| 89.7436% | |
| 83.0303% | |
| 81.2183% | |
| 82.8194% | |
| 84.0637% | |
| 72.449% | |
| 74.1379% | |
| 64.2857% | |
| 66.9565% | |
| 89.5522% | |
| 91.3333% | |
| 90.6977% | |
| 93.2642% | |
| 87.1795% | |
| 88.1988% | |
| 86.4865% | |
| 82.906% | |
| 84.5638% | |
| 84.4444% | |
| 85.0242% | |
| 82.2134% | |
| 85.2518% | |
| 86.3192% | |
| 87.9154% | |
| 83.1395% | |
| 86.9792% | |
| 86.6667% | |
| 85.6557% | |
| 84.9421% | |
| 85.5556% | |
| 87.8571% | |
| 87.3239% | |
| 88.255% | |
| 78.7879% | |
| 83.4646% | |
| 84.4444% | |
| 79.6053% | |
| 83.9744% | |
| 83.8983% | |
| 63.6364% | |
| 71.5385% | |
| 71.2329% | |
| -78.125% |